$20.51-0.14 (-0.68%)
Healthpeak Properties, Inc.
Healthpeak Properties, Inc. in the Real Estate sector is trading at $20.51 with a market capitalization of $14.7B. Wall Street consensus targets $23.05 (19 analysts), implying a +12.4% move over the next 12 months. The stock is currently 11% below its 52-week high of $22.95, remaining 12.6% above its 200-day moving average. On fundamentals, Piotroski 4/9 shows mixed financial quality, Altman Z in the distress zone. The Whystock Score of 60/100 suggests a balanced risk-reward profile.
| Metric (USD) | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 |
|---|---|---|---|---|---|
| Total Revenue | — | $752.95M↑ | $719.40M↑ | $705.87M↑ | $694.35M |
| Gross Profit | — | $429.09M↓ | $431.55M↑ | $413.95M↓ | $418.17M |
| Operating Income | — | $114.77M↓ | $145.84M↑ | $131.73M↑ | $131.49M |
| Net Income | — | $193.63M↑ | $113.97M↑ | -$117.12M↓ | $31.67M |
Healthpeak Properties, Inc. is a fully integrated real estate investment trust (REIT) and S&P 500 company. Healthpeak owns, operates, and develops high-quality real estate for healthcare discovery and delivery. Healthpeak Properties, Inc. is based in...

Healthpeak (DOC) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

DOC vs. EGP: Which Stock Is the Better Value Option?

Here is how Alexander's (ALX) and Healthpeak (DOC) have performed compared to their sector so far this year.
This article first appeared on GuruFocus. Healthpeak Properties Inc (NYSE:DOC) recently announced a total dividend of $0.1 per share, with the ex-dividend date set for 2026-09-14. This includes a $0.1 per share cash dividend payable on 2026-09-25.

Occupancy gains in lab and outpatient medical segments drive raised full-year guidance.
Academic risk and quality models computed from DOC's own filings and price history, not from analyst opinion.
Mixed: 4 of 9 fundamental-health tests pass, so profitability and balance-sheet trends disagree.
Altman Z below 1.81, the financial-distress band. This measures balance-sheet stress, not share-price direction.
Beneish M below the -1.78 flag threshold, so the earnings-manipulation model finds nothing unusual in the accruals and margin trends.
Share of earnings coming from accruals rather than cash. Higher values historically precede weaker future returns.
Hidden Markov model fitted to two years of returns, separating bull, bear and sideways states by their own drift and volatility.
GARCH(1,1) 30-day annualised forecast, above the current 30.4% reading.
Fama-French 5-factor market beta. The five factors explain 13% of this stock's return variance; the rest is idiosyncratic.
The stock’s own historical valuation anchor, which is a fairer comparison than a sector average for a company with a persistent premium or discount.
Model inputs as of 2026-09-08.